CD274 and neoplasm: For recurrent or distant cases that are not amenable to local treatment, systematic treatment is indicated: cases without PD-L1 expression are indicated for chemotherapy plus cetuximab; cases with PD-L1 expression and lower tumor burden are indicated for pembrolizumab monotherapy; cases with PD-L1 expression and high tumor burden are indicated for chemotherapy plus pembrolizumab.